Pacira BioSciences

PCRXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$984.589 M

$24.70 +2.45%

Close of 22 Sept 2026

Revenue

$726.4M

#1715 by revenue

Earnings

$7.00M

#2121 by earnings

Shares outstanding

39,861,886

Latest filing cover page

P/E ratio

140.7

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#158Amphastar PharmaceuticalsAMPH$1.03B
#159Arbutus BiopharmaABUS$991.2M
#160Pacira BioSciencesPCRX$984.6M
#161Lexicon PharmaceuticalsLXRX$970.0M
#162Immix BiopharmaIMMX$917.8M

What if Pacira BioSciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$758,468.12

Per share 30,707× higher

Bitcoin $1.74T

$43,692.24

Per share 1,769× higher

Nvidia $5.52T

$138,371.95

Per share 5,602× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Pacira BioSciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.